RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$3.17
+0.00 (+0.00%)
Performance
1D
—
1W
—
1M
—
3M
-25.41%
6M
-35.44%
1Y
-48.62%
YTD
-24.52%
Open$3.22
Previous Close$3.17
Day High$3.29
Day Low$3.11
52W High$7.18
52W Low$2.98
Volume—
Avg Volume12.91M
Market Cap1.78B
P/E Ratio—
EPS$-1.48
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.31
Below
SMA 200
$4.89
Below
RSI (14)
34.7
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
14 analysts
Price Target
+811.7% upside
Current
$3.17
$3.17
Target
$28.90
$28.90
$21.05
$28.90 avg
$39.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 87.65M | 71.09M | 309.68M |
| Net Income | -756,792,286 | -552,403,128 | -18,426,824 |
| Profit Margin | -863.4% | -820.2% | -6.0% |
| EBITDA | -722,497,674 | -556,668,929 | -21,116,374 |
| Free Cash Flow | — | — | -13,211,156 |
| Rev Growth | +23.3% | +23.3% | +0.8% |
| Debt/Equity | 0.02 | 0.02 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |